UK markets open in 5 hours 54 minutes

Biogen Inc. (BIIB.MX)

Mexico - Mexico Delayed price. Currency in MXN
Add to watchlist
5,508.42+118.42 (+2.20%)
At close: 12:53PM CDT
Sign in to post a message.
  • k
    kevin
    I have been a shareholder of Biogen for a long time, seen the ups and downs.. I’m not pushing this company on anyone, though I have studied this company for a long time. I believe that Biogen is a strong fundamental company that had many products in neuroscience that are in testing and in works to be approved soon..For example, they have 2 drugs coming out for 1) depression ( which is for millions of people) and 2) PPD ( another fir millions of people). The drug Toferson for ALS, even though wasn’t 100% successful, they still have many positive outcomes from and are continuing to work on it. Though ALS disease is really not a high population ( thankfully). The Alzheimer’s drug, Aduhelm, will be a success, it works definitely slows down the progression of Alzheimer’s. ( I’ve seen my mother in- law sue from it, it’s a fast moving disease, horrible). Any hospitals or insurance companies not covering it, will eventually cover it..
    They have many other drugs in the market helping people, along with many in the pipeline.
    As for the stock, this is very cheap. If I didn’t think they had much products to go on, I would leave the company. Do your research, this is an undervalued stock, that literally should be around 365… when the Depression and PPD drugs come to market, this will be 450..
    Just my opinion, but what do I know, I’m only a retired old analyst, who worked for an investment company dissecting companies products and financials..
    Good Luck, God Bless
    P.S. any feedback, please be intelligent thoughts,
  • O
    O-Behave
    $BIIB bought a whopping $750 million worth of shares in the 3rd quarter👀, reducing shares outstanding by 6% & board authorized purchase of up to $2.8 BILLION worth of shares! Keep sleeping 😴 on these gift prices.💸🛒✈📈
  • O
    O-Behave
    $BIIB trading LOWER than it was BEFORE FDA approval for its alzheimer drug. It's been bad mouthed so much that earnings expectations were set too low imo. Watch $BIIB blowout earnings. DON’T MISS this opportunity to load afterhours.
  • T
    TVN
    If recipients of Aduhelm claimed it does help them in slowing down memory loss and side effects are minimal then Aduhelm will be a blockbuster. Get to wait one or two more quarters just be patient
  • S
    SamIAm
    What do you make of the dismal sales of Aduhelm? Did they say numbers were moving up? Very discouraging I thought.
  • O
    O-Behave
    $BIIB looking so STRONG today. Analysts reiterated their BUY opinion. MAINTAINED $BIIB as an OVERWEIGHT. Must have been because BIIB stated they bought 750 million dollars worth of shares in the 3rd quarter at $341 PER SHARE and the board approved for an additional 2.8 billion dollar share buy back! $300 by next Friday
  • O
    O-Behave
    I think the $504 price target given by Truist today sounds the closest to where $BIIB is heading. The market is soaking up all the targets given by 7 analysts today. So much for the doom and gloom🤷‍♂️
  • R
    RNB
    Cantor Fitzgerald has lowered its price target on Biogen (NASDAQ:BIIB) to $427 from $435 (~50% upside) while maintaining a neutral recommendation.
  • O
    O-Behave
    $BIIB HUGE NEWS! Truist gives a $502 price target today!! Morgan Stanley gave a price target of $440! And a few more analysts. NONE of the professionals buying the doom & gloom smear campaign. It's RUNNING!💸
  • F
    Frozenspokes
    Aduhelm had just $300k in sales for Q3. At $56k a pop, you do the math on how many want to risk trying their drug. Sux for Alzheimer's sufferers that this doesn't work.
  • S
    SamIAm
    The ALS data must've leaked ahead of results being announced. Thus the herd of downgrades.
  • S
    Spike
    this stock reports earnings wednesday, given recent information about its pipeline, i think it heads to the $260 area? any thoughts.
  • S
    Saroj Nandi
    oversold...earnings pop...300 on d cards.
  • S
    SamIAm
    Tomorrow tells all!
  • O
    O-Behave
    Over the last 2 years, BIIB has beaten EPS estimates 88% of the time and has beaten revenue estimates 100% of the time. I'm so excited for tomorrow
  • O
    O-Behave
    $BIIB reached a high of $277 today. It's gonna break that today. OVERSOLD badly.
  • c
    chad
    Whether you agree with the drug approval or not, the reality is this is sitting at a valuation like the approval didn't happen at all.

    Earnings call expect a pop to $330, when the harsh truth is revealed that this drug is making them a lot of money.

    Protest the approval all you want, don't lose money over it though.
  • S
    SamIAm
    What were the downgrades based on? Other than the recent news that some MS medications could affect the covid vaccine I see nothing that has materially chsnged.
  • N
    Needla
    Here comes da good news
  • W
    William
    Yes, bought 100 shares premarket for 270.60 and sold a couple of minutes into normal trading for 277.00 for a $640.00 pop. ---Thank you lord